China's United Imaging Healthcare, a leading global medical imaging and radiotherapy equipment company, has annonced listing of initial public offering (IPO), on Shanghai stock exchange. 

United Imaging Healthcare expects to use the net proceeds from the IPO to fund its research and development of next-generation products, including high-end medical imaging equipment. Part of the funding will also go to industrialization projects and marketing service network projects, and serve as supplementary operating capital. 

By the end of 2021, United Imaging Healthcare had launched more than 80 groundbreaking products globally, including a Total-Body PET/CT, HD TOF PET/MR, 75cm Ultra-Wide Bore 3.0T MR, 640-Slice CT Scanner, and Fully Integrated CT-linac.

Based on the company's top technologies, it has established collaborations with many world-renowned clinical and scientific research institutions, including UC Davis, Washington University in St. Louis, Stony Brook University, King Hussein Cancer Center and Fujita Health University Hospital. So far, United Imaging Healthcare's products have been installed in medical and research institutions in more than 40 countries and regions, including the U.S., Japan, Italy, and New Zealand.